Table 4 The result summary of the first audit in 2010 and reaudit cycle in 2022.
From: Re-audit of the use of flumazenil following midazolam-induced conscious sedation
Standards | Compliance (%) (1st Cycle) | Compliance (%) (2nd Cycle) |
|---|---|---|
Standard 1: | ||
To write the justification of flumazenil use in the patient records and flumazenil drug book | 100% (32/32) | 100% (21/21) |
Standard 2: | ||
To write the timing of flumazenil use in: | ||
1. Patient records | 100% (32/32) | 0% (0/21) |
2. Flumazenil drug book | 100% (32/32) | 100% (0/21) |
Standard 3: | ||
To write discharge time in the patient’s record | 100% (32/32) | 0% (0/21) |
